Combined Treatment Modalities for Age Related Macular Degeneration

Publisher： Bentham Science Publishers

E-ISSN： 1873-5592|12|2|182-189

ISSN： 1389-4501

Source： Current Drug Targets, Vol.12, Iss.2, 2011-02, pp. : 182-189

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Age-Related Macular Degeneration: Epidemiology and Optimal Treatment

By Lacour M.  

Drugs & Aging, Vol. 19, Iss. 2, 2002-02 ,pp. : 101-133

Adis International

Access to resources Recommend Favorite

New therapies for the treatment of age-related macular degeneration

By Sarrafizadeh R.   Trese M.T.  

Expert Opinion on Therapeutic Patents, Vol. 10, Iss. 3, 2000-03 ,pp. : 333-341

Informa Healthcare

Access to resources Recommend Favorite

Treatment and Prevention of Age‐Related Macular Degeneration

By  

JOURNAL OF PHARMACY PRACTICE AND RESEARCH, Vol. 34, Iss. 1, 2004-03 ,pp. : 53-57

John Wiley & Sons Inc

Access to resources Recommend Favorite

Aflibercept (VEGF Trap-Eye) for the treatment of exudative age-related macular degeneration

By Stewart Michael W  

Expert Review of Clinical Pharmacology, Vol. 6, Iss. 2, 2013-03 ,pp. : 103-113

Informa Healthcare

Access to resources Recommend Favorite

Current and Future Treatment Options for Nonexudative and Exudative Age-Related Macular Degeneration

By Grant M. Comer  

Drugs & Aging, Vol. 21, Iss. 15, 2004-01 ,pp. : 967-992

Adis International

Access to resources Recommend Favorite